Therapeutically Targetable ALK Mutations in LeukemiaMaxson, J. E.; Davare, M. A.; Luty, S. B.; Eide, C. A.; Chang, B. H.; Loriaux, M. M.; Tognon, C. E.; Bottomly, D.; Wilmot, B.; McWeeney, S. K.; Druker, B. J.; Tyner, J. W. · Cancer Research · 2015

Chronic Myelogenous LeukemiaDruker, B. J. · Hematology · 2002

Chronic Myelogenous LeukemiaDruker, B. J. · Hematology · 2001

Molecularly Targeted Therapy: Have the Floodgates Opened?Druker, B. J. · The Oncologist · 2004

Imatinib As a Paradigm of Targeted TherapiesDruker, B. J. · Journal of Clinical Oncology · 2003

RNAi screen for rapid therapeutic target identification in leukemia patientsTyner, J. W.; Deininger, M. W.; Loriaux, M. M.; Chang, B. H.; Gotlib, J. R.; Willis, S. G.; Erickson, H.; Kovacsovics, T.; O'Hare, T.; Heinrich, M. C.; Druker, B. J. · Proceedings of the National Academy of Sciences · 2009

Translation of the Philadelphia chromosome into therapy for CMLDruker, B. J. · Blood · 2008

Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemiaLeonard, J. T.; Rowley, J. S. J.; Eide, C. A.; Traer, E.; Hayes-Lattin, B.; Loriaux, M.; Spurgeon, S. E.; Druker, B. J.; Tyner, J. W.; Chang, B. H. · Science Translational Medicine · 2016

Erratum:CancerSpectrum Knowledge Environment · 2002

Awards, Appointments, AnnouncementsCancerSpectrum Knowledge Environment · 2003

Attribution of Deaths Following Cancer TreatmentBegg, C. B. · CancerSpectrum Knowledge Environment · 2002

Ras and Seppuku in NeuroblastomaReynolds, C. P. · CancerSpectrum Knowledge Environment · 2002

A Hot Flash on Tamoxifen MetabolismGoetz, M. P. · CancerSpectrum Knowledge Environment · 2003

In BriefWang, L. · CancerSpectrum Knowledge Environment · 2003

In BriefWang, L. · CancerSpectrum Knowledge Environment · 2003

ErratumCancerSpectrum Knowledge Environment · 2003